Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
Shanghai Junshi Biosciences

May 2026

  • Home
  • Shanghai Junshi Biosciences

Shanghai Junshi Biosciences Market Share Analysis for May 2026

Company Introduction Founded in December 2012, Junshi Biosciences is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapeutics. With strong R&D capacity, Junshi Biosciences is at the cutting-edge of medical innovation. Our mission is to” Provide patients with world-class, trustworthy, affordable, and innovative drugs”. We have established a globally integrated […]
Year Founded2012
Employees1001 - 5000
Annual Revenue$200M - $500M
junshipharma.com
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (including company regionals)
  • junshipharma.com
    junshipharma.com
See more website traffic and engagement information

Shanghai Junshi Biosciences Revenue up to May 2026 is 200M - 500M

revenue generated by Shanghai Junshi Biosciences top domains

Shanghai Junshi Biosciences top domains revenue over 3 years

Revenue for Shanghai Junshi Biosciences top domains

junshipharma.comjunshipharma.com200M - 500M
See more with Sales Intelligence

Total visits to Shanghai Junshi Biosciences's top domains

Understand Shanghai Junshi Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Shanghai Junshi Biosciences's top domains

Analyze Shanghai Junshi Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
junshipharma.comjunshipharma.com00:00:38
See more with Sales Intelligence

Avg. pageviews on Shanghai Junshi Biosciences's top domains

See how Shanghai Junshi Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Shanghai Junshi Biosciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Shanghai Junshi Biosciences

These are the website technologies, by industry, used by Shanghai Junshi Biosciences top domains

Content Management System (3)

WordPress

WordPress

Mobile (2)

Meta Viewport

Meta Viewport

Multilingual (2)

Multilingual Support

Multilingual Support

Widget (2)

Yoast SEO

Yoast SEO

More Technologies

4

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Shanghai Junshi Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAntengene Corporation partners with Junshipharma.Antengene enters into collaboration with Junshi Biosciences to evaluate ATG-037 and JS207 in solid tumours.
NewsJunshipharma partnered with Leo Pharma Inc. on Jan 20th '25.SHANGHAI, China I January 20, 2025 I Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe.
NewsJunshipharma launches TORCHLIGHT Phase 3 study in Nature Medicine.Shanghai Junshi Biosciences, a biopharmaceutical frontrunner, has announced the findings of the TORCHLIGHT Phase 3 study in Nature Medicine, unveiling the effectiveness and safety of toripalimab in tandem with nab-paclitaxel for patients suffering from advanced triple-negative breast cancer (TNBC).

See all Shanghai Junshi Biosciences signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.